Evidence map›Paper›PMID 41841453›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Alkoxysulfonium Salts Unlock Access to New Aryl Sulfonium Salts for Cross-Coupling.

Rachel E Brown, Navpreet Kaur, Anne-Chloe M A Nassoy, Ciro Romano, David J Procter

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rachel E BrownDepartment of Chemistry, The University of Manchester, Manchester, UK.
Navpreet KaurDepartment of Chemistry, The University of Manchester, Manchester, UK.
Anne-Chloe M A NassoyOncology Targeted Discovery, AstraZeneca UK Limited, Cambridge, UK.
Ciro RomanoDepartment of Chemistry, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0001-7957-2316
David J ProcterDepartment of Chemistry, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0003-3179-2509

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aryl sulfonium salts are indispensable partners in cross-coupling reactions, allowing access to aryl metal or aryl radical intermediates, and offering advantages over aryl halides or other pseudohalides. Routes to aryl sulfonium salts are limited; the standard approach involves activation of arenes using a sulfoxide-derived electrophile. While the activation of non-prefunctionalized arene partners is attractive, the method is limited to arenes that are sufficiently electron-rich to engage with sulfur electrophiles and is often dominated by para-selectivity when monosubstituted benzenes are used. This limited access to aryl sulfonium salts leads to biased substrate scopes and restrictions on accessible chemical space. We describe a route to otherwise hard-to-access (hetero)aryl sulfonium salts that exploits bench-stable alkoxysulfonium salts in combination with the well-established magnesiation of readily available aryl bromides. The approach allows access to aryl sulfonium salts bearing electron-deficient aryl and heteroaryl rings, or electron-rich systems in which the sulfonium motif resides at an alternative position on the ring to that delivered by electrophilic arene sulfenylation. To illustrate their value, the new sulfonium salts have been used to expand the scope of a selection of coupling processes.

Indexed as

cross‐couplingGrignardligand‐couplingphotochemistrysulfonium salt

Identifiers

PMID41841453
PMCPMC13098308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.